New pill shows promise for gut disease relief
Disease control
Ongoing
This study tests a new drug called Hemay005 in people with moderate to severe ulcerative colitis, a condition causing inflammation in the colon. About 92 adults will receive either a low dose, high dose, or a placebo for 12 weeks. The goal is to see if the drug can reduce symptom…
Phase: PHASE2 • Sponsor: Ganzhou Hemay Pharmaceutical Co., Ltd • Aim: Disease control
Last updated May 13, 2026 16:02 UTC